Results 161 to 170 of about 54,277 (273)

Paediatric Autoimmune Thyroiditis Triggered by Prior SARS-CoV-2 Exposure: A Case with Transient Hashitoxicosis. [PDF]

Eur J Case Rep Intern Med
Rodina L, Caplan LG, Ciudin EV, Cocuz ME, Birlutiu V.   +4 more
europepmc   +1 more source

Spatially Resolved Multiomics Reveals Metabolic Remodeling and Autophagy Activation in Adamantinomatous Craniopharyngiomas

Advanced Science, Volume 13, Issue 17, 23 March 2026.
Multiomics integration analysis reveals the “cystic fluid–tumor cell” metabolic coupling that mediates active choline/ethanolamine uptake of tumor cells from cystic fluid and PC/PE synthesis pathways reprogramming that mediating autophagy pathway activation within ACP. ABSTRACT Adamantinomatous craniopharyngioma (ACP), a benign yet highly recurrent and
Dongting Chen, Yahui Gao, Yulin Wang, Ting Lei, Zheng Qu, Yuhan An, Jiaxu Fu, Xin Li, Fangjun Liu, Yan Li   +9 more
wiley   +1 more source

CRISPR screens identify PRMT7 as a therapeutic target to enhance T cell-mediated killing in breast cancer. [PDF]

NPJ Breast Cancer
Shi W, Luo Y, Wang Y, Burrows JM, Black D, Civitarese A, Perlaza-Jimenez L, Zhang P, Manning M, Tuano N, Rentería ME, Xiao C, Tey SK, Rosenbluh J, Smith C, Chenevix-Trench G, Beesley J.   +16 more
europepmc   +1 more source

Expression and immmunogenicity of HLA-B27 in high-transfection recipient P815: [PDF]

, 1989
Kuon, W., Riethmüller, Gert, Thureau, S. R., Weiss, Elisabeth H., Wildner, G.   +4 more
core   +1 more source

Cytokine‐Engineered Chimeric Antigen Receptor‐T Cell Therapy: How to Balance the Efficacy and Toxicity

Advanced Science, Volume 13, Issue 14, 9 March 2026.
Cytokine‐engineered CAR‐T cells represent a promising immunotherapy against malignancies due to direct tumor killing and potent immunity response. However, significant toxicities, including CRS and ICANS, have restricted clinical applications. How to keep the risk‐benefit balance of the advanced therapy is of great importance for maximizing the benefit
Xinru Zhang, Gulizeba Aimaiti, Yuanye Guan, Yuzhe Sha, Wei Zhou, Jiefeng Shen, Bo Zhao, Wei‐En Yuan   +7 more
wiley   +1 more source

Triple autoimmune overlap syndrome of the liver: a rare case of concomitant PBC, PSC, and AIH. [PDF]

Future Sci OA
Hassen H, Dahmani W, Bedoui G, Sakly S, Souilem E, Ghdiri Y, Jaziri H, Ben Slema A, Brahem A, Elleuch N, Ksiaa M.   +10 more
europepmc   +1 more source

Genetic Alterations Involved in Immune Escape Mechanisms of Circulating Tumour Cells in Colorectal Carcinogenesis

Cancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT In colorectal cancer (CRC), circulating tumour cells (CTCs) employ genetic alterations to dodge the body's immune system. These alterations occur in specific “driver” genes, including KRAS, BRAF, p53, MYC, APC and PTEN. Changes in these genes can control how the tumour interacts with the immune system and influence the expression of immune ...
Sharmin Aktar, Matthew Masoudi, Dilpreet Moti, Vinod Gopalan, Farhadul Islam, Alfred King‐yin Lam   +5 more
wiley   +1 more source

Challenges in Diagnosing and Managing Hepatitis E in Transplant Recipients: A Case Report. [PDF]

Case Rep Transplant
Martins AC, Pimenta G, Mascarenhas A, Veríssimo R, Querido S, Weigert A.   +5 more
europepmc   +1 more source

Lack of De‐Intensification Models for Female Head and Neck Cancer Patients With Favorable Prognosis

Cancer Medicine, Volume 15, Issue 3, March 2026.
ABSTRACT Purpose The prognostic relevance of gender in head and neck cancer is often neglected. In contrast, the more favorable prognosis of human papillomavirus (HPV)‐associated oropharyngeal squamous cell carcinoma (OPSCC) is well recognized, and de‐escalation strategies are increasingly being tested in clinical trials.
J. M. Vahl, J. Hahn, A. von Witzleben, S. M. Schroeder, C. Idel, B. Wollenberg, T. K. Hoffmann, S. Laban   +7 more
wiley   +1 more source

A pharmacovigilance study of daptomycin use in infants under 1 year old based on the FDA adverse event reporting system. [PDF]

Sci Rep
Ye L, Guo G, Zhou H, Chen M, Fan Z, Zhang J.   +5 more
europepmc   +1 more source